Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities.

Purpose: To evaluate the impact of the number of comorbidities on virologic suppression in HIV-positive patients.

Methods: This study included patients 18 years or older who were on antiretroviral therapy (ART) with at least 2 visits to an HIV primary care clinic in the past year. The primary outcome was the percentage of patients with an undetectable viral load (a blood HIV RNA level of <20 copies/mL) among groups of patients with 0, 1 or 2, 3 or 4, and 5 comorbidities, respectively.